Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic

INTRODUCTION: Dimethyl fumarate (DMF) is approved as oral systemic treatment for moderate-to-severe psoriasis. Scarce evidence is available for DMF treatment in psoriatic patients at the time of COVID-19 pandemic. The objective of this study was to assess the long-term effectiveness and safety of DM...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Maria, Campanati, Anna, Giunta, Alessandro, Calianno, Gianluca, Bianchi, Luca, Diotallevi, Federico, Offidani, Anna Maria, Fargnoli, Maria Concetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805130/
https://www.ncbi.nlm.nih.gov/pubmed/35103934
http://dx.doi.org/10.1007/s13555-022-00684-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805130/
https://www.ncbi.nlm.nih.gov/pubmed/35103934
http://dx.doi.org/10.1007/s13555-022-00684-3

Ejemplares similares